Ftse Mib
33.746,66
0,00%
DAX
17.932,17
-1,10%
S&P 500
5.018,39
-0,34%
NASDAQ Composite
15.605,48
-0,33%
Bitcoin
57.682,95
-0,95%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Titan Pharmaceuticals Inc (TTNP) Titan Pharmaceuticals Inc (TTNP) Notizie

Titan Pharmaceuticals Inc

TTNP
6,70
-0,005 (-0,07%)
02 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
25/1/202422:33EDGAR2Form 8-K - Current report
25/1/202422:29GLOBETitan Pharmaceuticals Fully Compliant With NASDAQ Listing..
18/1/202422:59EDGAR2Form 8-K - Current report
08/1/202423:13EDGAR2Form 8-K - Current report
28/12/202322:30EDGAR2Form 8-K - Current report
28/12/202322:15GLOBETitan Pharmaceuticals Announces Reverse Stock Split and..
28/11/202322:47EDGAR2Form DEF 14A - Other definitive proxy statements
17/11/202322:03EDGAR2Form PRE 14A - Other preliminary proxy statements
15/11/202322:05EDGAR2Form 8-K - Current report
26/10/202322:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/10/202322:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/10/202322:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/10/202322:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/10/202322:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202323:26EDGAR2Form S-8 - Securities to be offered to employees in employee..
23/10/202321:07EDGAR2Form 3 - Initial statement of beneficial ownership of..
16/10/202323:08EDGAR2Form 8-K - Current report
16/10/202322:37GLOBETitan Pharmaceuticals Announces Appointment of Dato' Seow..
04/10/202323:30EDGAR2Form SC 13D - General statement of acquisition of beneficial..
19/9/202322:41EDGAR2Form 8-K/A - Current report: [Amend]
18/9/202322:45EDGAR2Form 8-K - Current report
18/9/202313:30GLOBETitan Pharmaceuticals Announces $9.5 Million Private..
08/9/202323:30EDGAR2Form 8-K - Current report
30/8/202322:28EDGAR2Form 8-K - Current report
14/8/202323:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/8/202302:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202301:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202301:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/7/202323:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/7/202323:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/7/202323:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/7/202323:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/7/202313:30GLOBETitan Pharmaceuticals Announces Sale of Certain ProNeura..
21/7/202303:57EDGAR2Form SC 13D - General statement of acquisition of beneficial..
07/7/202316:28EDGAR2Form 8-K - Current report
29/6/202322:15EDGAR2Form 8-K - Current report
Apertura: 6,60 Min: 6,60 Max: 7,04
Chiusura: 6,705

La tua Cronologia

NASDAQ
TTNP
Titan Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network